We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+26.16%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$11.4B
AUM Growth
+$1.76B
(+18%)
Cap. Flow
-$330M
Cap. Flow
% of AUM
-2.89%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
1,151
New
138
Increased
341
Reduced
503
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$32.1M |
| 2 |
Intel
INTC
|
+$28.7M |
| 3 |
Gilead Sciences
GILD
|
+$27.7M |
| 4 |
APA Corp
APA
|
+$27.5M |
| 5 |
Costco
COST
|
+$25.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OPTU
Optimum Communications Inc
OPTU
|
+$41M |
| 2 |
Align Technology
ALGN
|
+$38.9M |
| 3 |
Qualcomm
QCOM
|
+$33.6M |
| 4 |
H&R Block
HRB
|
+$31.8M |
| 5 |
CBRE Group
CBRE
|
+$28.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.64% |
| 2 | Healthcare | 14.08% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 13.05% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
First Commonwealth Financial
FCF
$2.2B
| $424K | ﹤0.01% |
38,762
-1,464
| -4% | -$14K |
|
877
Collegium Pharmaceutical
COLL
$1.18B
| $419K | ﹤0.01% |
+20,930
| New | +$409K |
|
|
MRLN
878
DELISTED
Marlin Business Services Corp
MRLN
| $415K | ﹤0.01% |
33,917
+2,815
| +9% | +$27.5K |
|
|
CHCT
879
Community Healthcare Trust
CHCT
$536M
| $411K | ﹤0.01% |
+8,718
| New | +$415K |
|
|
STXB
880
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $406K | ﹤0.01% |
24,150
-16
| -0.1% | -$240 |
|
881
Fossil Group
FOSL
$260M
| $397K | ﹤0.01% |
45,835
-637,424
| -93% | -$5.36M |
|
|
QVCGA
882
DELISTED
QVC Group Inc Series A
QVCGA
| $396K | ﹤0.01% |
723
-100
| -12% | -$45K |
|
883
Adicet Bio
ACET
$77.6M
| $386K | ﹤0.01% |
1,719
| – | – |
|
884
Green Brick Partners
GRBK
$3.09B
| $386K | ﹤0.01% |
16,830
-1,302
| -7% | -$27.2K |
|
885
Gyre Therapeutics
GYRE
$629M
| $382K | ﹤0.01% |
8,064
-8,586
| -52% | -$372K |
|
886
Energy Recovery
ERII
$420M
| $379K | ﹤0.01% |
27,812
-6,746
| -20% | -$72K |
|
|
ZYNE
887
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $378K | ﹤0.01% |
+114,439
| New | +$435K |
|
888
Realty Income
O
$61.1B
| $377K | ﹤0.01% |
6,263
| – | – |
|
889
Home Bancorp
HBCP
$558M
| $374K | ﹤0.01% |
13,377
+1,125
| +9% | +$30.9K |
|
890
Procter & Gamble
PG
$340B
| $368K | ﹤0.01% |
2,648
-63
| -2% | -$8.8K |
|
|
AGTC
891
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $368K | ﹤0.01% |
89,908
+18,047
| +25% | +$88.6K |
|
892
Outlook Therapeutics
OTLK
$187M
| $360K | ﹤0.01% |
13,829
-908
| -6% | -$19K |
|
893
Jacobs Solutions
J
$16B
| $359K | ﹤0.01% |
3,984
-1,074
| -21% | -$91K |
|
894
Valhi
VHI
$389M
| $359K | ﹤0.01% |
23,595
| – | – |
|
|
GRTX
895
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $358K | ﹤0.01% |
34,966
-62
| -0.2% | -$678 |
|
896
Resources Connection
RGP
$140M
| $357K | ﹤0.01% |
28,422
-1,076
| -4% | -$12.9K |
|
|
CMBM
897
DELISTED
Cambium Networks
CMBM
| $352K | ﹤0.01% |
14,055
-2,933
| -17% | -$67.7K |
|
898
J.M. Smucker
SJM
$13.5B
| $349K | ﹤0.01% |
3,019
-2,057
| -41% | -$239K |
|
899
STRATTEC Security
STRT
$376M
| $344K | ﹤0.01% |
6,961
-3,747
| -35% | -$133K |
|
900
Bank First Corp
BFC
$1.68B
| $339K | ﹤0.01% |
+5,231
| New | +$343K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2020 Portfolio in Review
As of Q4 2020, Jacobs Levy Equity Management held 1,151 positions worth $11.4B, up 18% from $9.65B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2020 filing shows 138 new, 341 increased, 503 reduced and 146 closed positions. Its largest new stake was DexCom: 229,736 shares worth $21.2M. The largest sale was Optimum Communications Inc, an estimated $41M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2020 buy was DexCom: 229,736 shares worth $21.2M.
- Jacobs Levy Equity Management added most to Amazon in Q4 2020, an estimated $32.1M increase.
- Jacobs Levy Equity Management's biggest Q4 2020 reduction was Qualcomm, cutting an estimated $33.6M.
- Jacobs Levy Equity Management fully exited Optimum Communications Inc in Q4 2020, selling an estimated $41M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $11.4B portfolio in Q4 2020.
- Jacobs Levy Equity Management opened 138 new positions and closed 146 in Q4 2020.
- Jacobs Levy Equity Management's portfolio value rose 18% quarter-over-quarter to $11.4B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.